Background: Ovarian cancer is the most malignant tumor in gynecological tumors, with low five-year
survival rate. The main reasons are diagnosis at advanced stages (the early symptoms are uncharacteristic, and
most are diagnosedlate.), relapse, and resistance to existing chemotherapy drugs.
Methods: Search strategy was performed in the following steps. Firstly, LncRNA related to ovarian cancer was
retrieved by using the LncRNA Disease database, and articles were searched by searching keywords: ovarian
cancer, drug resistance, and LncRNA retrieved from the LncRNA Disease database.
Results/Conclusion: With the development of the study on drug resistance of ovarian cancer, the role of
LncRNAs as sensitive biomarker and therapeutic target has emerged, providing a direction for precision medicine
of ovarian cancer resistance.